Nu Skin Enterprises (NUS) Releases Q1 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its first quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.70-0.77 for the period, compared to the Thomson Reuters consensus estimate of $0.77. The company issued revenue guidance of $615-635 million, compared to the consensus revenue estimate of $625.56 million.Nu Skin Enterprises also updated its FY 2019 guidance to $3.80-4.05 EPS.

NUS traded up $0.95 during trading on Wednesday, hitting $69.50. 692,400 shares of the company traded hands, compared to its average volume of 538,257. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of 21.52, a PEG ratio of 1.53 and a beta of 0.69. Nu Skin Enterprises has a 1 year low of $56.09 and a 1 year high of $88.68. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.25 and a current ratio of 1.93.

NUS has been the subject of several research analyst reports. Bank of America reaffirmed an underperform rating and set a $65.00 target price (down from $75.00) on shares of Nu Skin Enterprises in a research note on Thursday, December 6th. Citigroup set a $88.00 target price on shares of Nu Skin Enterprises and gave the company a buy rating in a research note on Thursday, November 8th. Jefferies Financial Group reaffirmed a buy rating and set a $92.00 target price on shares of Nu Skin Enterprises in a research note on Thursday, November 8th. Tigress Financial reaffirmed a buy rating on shares of Nu Skin Enterprises in a research note on Wednesday, November 21st. Finally, Zacks Investment Research cut shares of Nu Skin Enterprises from a hold rating to a sell rating in a research note on Tuesday, January 8th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. Nu Skin Enterprises has an average rating of Buy and an average price target of $81.13.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 1,250 shares of Nu Skin Enterprises stock in a transaction on Wednesday, January 2nd. The shares were sold at an average price of $60.60, for a total value of $75,750.00. Following the completion of the transaction, the general counsel now directly owns 32,621 shares of the company’s stock, valued at approximately $1,976,832.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.00% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Featured Article: What is the downside to momentum investing?

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit